These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 25967129)

  • 1. A retrospective study on the outcomes of MPO-ANCA-associated vasculitis in dialysis-dependent patients.
    Hasegawa M; Hattori K; Sugiyama S; Asada H; Yamashita H; Takahashi K; Hayashi H; Koide S; Sato W; Yuzawa Y
    Mod Rheumatol; 2016; 26(1):110-4. PubMed ID: 25967129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myeloperoxidase-Antineutrophil Cytoplasmic Antibody (ANCA)-Positive Granulomatosis With Polyangiitis (Wegener's) Is a Clinically Distinct Subset of ANCA-Associated Vasculitis: A Retrospective Analysis of 315 Patients From a German Vasculitis Referral Center.
    Schirmer JH; Wright MN; Herrmann K; Laudien M; Nölle B; Reinhold-Keller E; Bremer JP; Moosig F; Holle JU
    Arthritis Rheumatol; 2016 Dec; 68(12):2953-2963. PubMed ID: 27333332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long term azathioprine maintenance therapy in ANCA-associated vasculitis: combined results of long-term follow-up data.
    de Joode AAE; Sanders JSF; Puéchal X; Guillevin LP; Hiemstra TF; Flossmann O; Rasmussen N; Westman K; Jayne DR; Stegeman CA
    Rheumatology (Oxford); 2017 Nov; 56(11):1894-1901. PubMed ID: 28977502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association Between Reappearance of Myeloperoxidase-Antineutrophil Cytoplasmic Antibody and Relapse in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Subgroup Analysis of Nationwide Prospective Cohort Studies.
    Watanabe H; Sada KE; Matsumoto Y; Harigai M; Amano K; Dobashi H; Fujimoto S; Usui J; Yamagata K; Atsumi T; Banno S; Sugihara T; Arimura Y; Matsuo S; Makino H;
    Arthritis Rheumatol; 2018 Oct; 70(10):1626-1633. PubMed ID: 29790303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increase of Antimyeloperoxidase Antineutrophil Cytoplasmic Antibody (ANCA) in Patients with Renal ANCA-associated Vasculitis: Association with Risk to Relapse.
    Yamaguchi M; Ando M; Kato S; Katsuno T; Kato N; Kosugi T; Sato W; Tsuboi N; Yasuda Y; Mizuno M; Ito Y; Matsuo S; Maruyama S
    J Rheumatol; 2015 Oct; 42(10):1853-60. PubMed ID: 26373560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical characteristics and outcomes of childhood-onset ANCA-associated vasculitis: a French nationwide study.
    Sacri AS; Chambaraud T; Ranchin B; Florkin B; Sée H; Decramer S; Flodrops H; Ulinski T; Allain-Launay E; Boyer O; Dunand O; Fischbach M; Hachulla E; Pietrement C; Le Pogamp P; Stephan JL; Belot A; Nivet H; Nobili F; Guillevin L; Quartier P; Deschênes G; Salomon R; Essig M; Harambat J
    Nephrol Dial Transplant; 2015 Apr; 30 Suppl 1():i104-12. PubMed ID: 25676121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Difference in relapse-rate and clinical phenotype by autoantibody-subtype in Japanese patients with anti-neutrophil cytoplasmic antibody-associated vasculitis.
    Murosaki T; Sato T; Akiyama Y; Nagatani K; Minota S
    Mod Rheumatol; 2017 Jan; 27(1):95-101. PubMed ID: 27320904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical impact of subgrouping ANCA-associated vasculitis according to antibody specificity beyond the clinicopathological classification.
    Deshayes S; Martin Silva N; Khoy K; Yameogo S; Mariotte D; Lobbedez T; Aouba A
    Rheumatology (Oxford); 2019 Oct; 58(10):1731-1739. PubMed ID: 30805643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ANCA-associated vasculitis with renal involvement: an outcome analysis.
    Weidner S; Geuss S; Hafezi-Rachti S; Wonka A; Rupprecht HD
    Nephrol Dial Transplant; 2004 Jun; 19(6):1403-11. PubMed ID: 15069175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myeloperoxidase-Antineutrophil Cytoplasmic Antibody (ANCA)-Positive and ANCA-Negative Patients With Granulomatosis With Polyangiitis (Wegener's): Distinct Patient Subsets.
    Miloslavsky EM; Lu N; Unizony S; Choi HK; Merkel PA; Seo P; Spiera R; Langford CA; Hoffman GS; Kallenberg CG; St Clair EW; Tchao NK; Fervenza F; Monach PA; Specks U; Stone JH
    Arthritis Rheumatol; 2016 Dec; 68(12):2945-2952. PubMed ID: 27428559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The initial predictors of death in 153 patients with ANCA-associated vasculitis in a single Korean centre.
    Mun CH; Yoo J; Jung SM; Song JJ; Park YB; Lee SW
    Clin Exp Rheumatol; 2018; 36 Suppl 111(2):65-72. PubMed ID: 29465370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maintenance of Remission and Risk of Relapse in Myeloperoxidase-Positive ANCA-Associated Vasculitis with Kidney Involvement.
    Casal Moura M; Specks U; Tehranian S; Sethi S; Zubidat D; Nardelli L; Dos Santos FG; Sousa C; León-Róman J; Bobart SA; Greene E; Zand L; Fervenza FC
    Clin J Am Soc Nephrol; 2023 Jan; 18(1):47-59. PubMed ID: 36526414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrences and infections during continuous immunosuppressive therapy after beginning dialysis in ANCA-associated vasculitis.
    Weidanz F; Day CJ; Hewins P; Savage CO; Harper L
    Am J Kidney Dis; 2007 Jul; 50(1):36-46. PubMed ID: 17591523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Negative anti-neutrophil cytoplasm antibody at switch to maintenance therapy is associated with a reduced risk of relapse.
    Morgan MD; Szeto M; Walsh M; Jayne D; Westman K; Rasmussen N; Hiemstra TF; Flossmann O; Berden A; Höglund P; Harper L;
    Arthritis Res Ther; 2017 Jun; 19(1):129. PubMed ID: 28592297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extended versus standard azathioprine maintenance therapy in newly diagnosed proteinase-3 anti-neutrophil cytoplasmic antibody-associated vasculitis patients who remain cytoplasmic anti-neutrophil cytoplasmic antibody-positive after induction of remission: a randomized clinical trial.
    Sanders JS; de Joode AA; DeSevaux RG; Broekroelofs J; Voskuyl AE; van Paassen P; Kallenberg CG; Tervaert JW; Stegeman CA
    Nephrol Dial Transplant; 2016 Sep; 31(9):1453-9. PubMed ID: 27242368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A preliminary study of the significance of autoantibodies against light chain of myeloperoxidase on pulmonary damages in myeloperoxidase-antineutrophil cytoplasmic antibody associated vasculitis].
    Zhang L; Shuai Z; Hu Z; Zhang M; Chen S
    Zhonghua Nei Ke Za Zhi; 2015 Jun; 54(6):511-6. PubMed ID: 26359012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of pulse methylprednisolone induction therapy in Chinese patients with dialysis-dependent MPO-ANCA associated vasculitis.
    Huang L; Zhong Y; Ooi JD; Zhou YO; Zuo X; Luo H; Chen JB; Wu T; Yang Y; Meng T; Xiao Z; Lin W; Ao X; Xiao X; Zhou Q; Xiao P
    Int Immunopharmacol; 2019 Nov; 76():105883. PubMed ID: 31536905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and prognostic features of Korean patients with MPO-ANCA, PR3-ANCA and ANCA-negative vasculitis.
    Yoo J; Kim HJ; Ahn SS; Jung SM; Song JJ; Park YB; Lee SW
    Clin Exp Rheumatol; 2017; 35 Suppl 103(1):111-118. PubMed ID: 28339364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical analysis of patients with myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitis.
    Shuai ZW; Lv YF; Zhang MM; Hu ZY
    Genet Mol Res; 2015 May; 14(2):5296-303. PubMed ID: 26125725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Anti-neutrophil cytoplasmic antibody-associated vasculitis. Clinical aspects and treatment].
    Paolini MV; Ruffino JP; Fernández Romero DS
    Medicina (B Aires); 2013; 73(2):119-26. PubMed ID: 23570759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.